Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
LFCR
LIFECORE BIOMEDICAL INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$285.10M$7.70-2.04%-$14.23M-5.20x85.36
United States
CVAC
CUREVAC NV
NASDAQ
Biotechnology
$1.21B$5.360.19%$278.40M5.30x0.18
Germany
MNKD
MANNKIND CORP
NASDAQ
Biotechnology
$1.65B$5.390.37%$79.10M49.00x-8.48
United States
SLNO
SOLENO THERAPEUTICS INC
NASDAQ
Biotechnology
$2.71B$50.982.55%-$175.43M-12.23x0.38
United States
INSP
INSPIRE MEDICAL SYSTEMS INC
NYSE
Medical Devices
$2.37B$80.00-0.99%$69.12M44.69x0.18
United States
ALC
ALCON INC
NYSE
Medical Instruments & Supplies
$38.17B$77.20-0.57%$2.60B35.58x0.42
United States
KZIA
KAZIA THERAPEUTICS LTD
NASDAQ
Biotechnology
$5.29M$7.94-0.87%N/A-0.35x-0.85
Australia
ACRS
ACLARIS THERAPEUTICS INC
NASDAQ
Diagnostics & Research
$195.99M$1.81-1.63%-$129.52M-1.14x0.38
United States
LENZ
LENZ THERAPEUTICS INC
NASDAQ
Biotechnology
$1.20B$42.232.28%-$51.81M-22.83x0.05
United States
QIPT
QUIPT HOME MEDICAL CORP
NASDAQ
Medical Devices
$116.43M$2.681.90%$48.06M-11.17x1.30
United States
QNTM
QUANTUM BIOPHARMA LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$61.64M$17.776.73%-$18.92M-1.85x3.52
Canada
BFLY
BUTTERFLY NETWORK INC
NYSE
Medical Devices
$410.34M$1.630.00%-$51.92M-5.82x0.35
United States
MAZE
MAZE THERAPEUTICS INC
NASDAQ
Biotechnology
$1.03B$23.500.17%N/AN/A0.16
United States
OM
OUTSET MEDICAL INC
NASDAQ
Medical Devices
$246.87M$13.930.58%-$84.88M-0.48x0.77
United States
EVO
EVOTEC SE
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.29B$3.64-1.36%N/A-7.19x1.14
Germany
RARE
ULTRAGENYX PHARMACEUTICAL INC
NASDAQ
Biotechnology
$2.77B$28.71-2.61%-$494.95M-5.20x7.96
United States
ARWR
ARROWHEAD PHARMACEUTICALS INC
NASDAQ
Biotechnology
$4.02B$29.13-0.99%-$57.42M-21.42x1.30
United States
NSRX
NASUS PHARMA LTD
NYSEMKT
Drug Manufacturers - General
N/A$8.13-0.06%-$1.50M-36.93x-1.22
Israel
CDTX
CIDARA THERAPEUTICS INC
NASDAQ
Biotechnology
$841.09M$64.850.22%-$181.59M-2.49x0.35
United States
ANIK
ANIKA THERAPEUTICS INC
NASDAQ
Medical Devices
$124.86M$8.660.12%-$48.18M-2.09x0.27
United States
TCRX
TSCAN THERAPEUTICS INC
NASDAQ
Biotechnology
$90.80M$1.60-6.98%-$130.55M-1.47x0.69
United States
SNDA
SONIDA SENIOR LIVING INC
NYSE
Medical Care Facilities
$496.55M$26.380.61%$56.46M-10.99x12.98
United States
PGEN
PRECIGEN INC
NASDAQ
Biotechnology
$1.14B$3.82-1.80%-$121.98M-9.10x-2.93
United States
ZLAB
ZAI LAB LTD
NASDAQ
Biotechnology
$3.53B$32.580.87%-$227.62M-13.58x0.45
China
AGEN
AGENUS INC
NASDAQ
Biotechnology
$144.98M$4.551.79%-$69.99M-0.65x-1.47
United States
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$7.71B$15.609.01%-$3.56M-1,733.33x0.03
Hong Kong
UTHR
UNITED THERAPEUTICS CORP
NASDAQ
Biotechnology
$18.26B$403.681.43%$1.73B14.58x0.10
United States
PBH
PRESTIGE CONSUMER HEALTHCARE INC
NYSE
Drug Manufacturers - Specialty & Generic
$3.15B$63.820.98%$369.24M14.77x0.85
United States
SGRY
SURGERY PARTNERS INC
NASDAQ
Medical Care Facilities
$2.79B$21.791.07%$377.20M-15.24x2.75
United States
CTEV
CLARITEV CORP
NYSE
Health Information Services
$917.64M$55.83-2.17%-$523.35M-0.77x341.97
United States
TSHA
TAYSHA GENE THERAPIES INC
NASDAQ
Biotechnology
$791.11M$2.902.11%-$90.24M-8.53x0.34
United States
GERN
GERON CORP
NASDAQ
Biotechnology
$810.28M$1.271.60%-$58.41M-9.77x1.14
United States
PMI
PICARD MEDICAL INC
NYSEMKT
Medical Devices
$558.65M$7.58-0.26%N/AN/A-0.84
United States
NRSN
NEUROSENSE THERAPEUTICS LTD
NASDAQ
Biotechnology
$29.03M$1.180.85%-$8.86M-3.28x-4.25
Israel
OMDA
OMADA HEALTH INC
NASDAQ
Health Information Services
N/A$22.53-4.86%N/AN/A-0.21
United States
AMLX
AMYLYX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.14B$12.776.77%-$218.75M-4.12x0.09
United States
GALT
GALECTIN THERAPEUTICS INC
NASDAQ
Biotechnology
$294.04M$4.594.08%-$33.52M-7.17x-1.12
United States
STOK
STOKE THERAPEUTICS INC
NASDAQ
Biotechnology
$1.25B$22.74-1.81%$44.92M24.99x0.15
United States
KROS
KEROS THERAPEUTICS INC
NASDAQ
Biotechnology
$634.41M$15.62-1.14%$30.57M42.22x0.07
United States
PVLA
PALVELLA THERAPEUTICS INC
NASDAQ
Biotechnology
$625.65M$56.573.78%-$20.38M-20.35x0.54
United States
NVAX
NOVAVAX INC
NASDAQ
Biotechnology
$1.36B$8.39-1.99%$495.57M3.23x34.52
United States
MDXH
MDXHEALTH SA
NASDAQ
Diagnostics & Research
$18.22M$3.68-3.16%-$6.46M-0.49x-160.27
Belgium
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS INC
NASDAQ
Biotechnology
$15.11M$5.630.00%-$3.31M-3.88x0.31
United States
NAMS
NEWAMSTERDAM PHARMA CO NV
NASDAQ
Biotechnology
$2.76B$24.49-0.12%-$192.49M-13.00x0.05
Netherlands
SEER
SEER INC
NASDAQ
Biotechnology
$116.06M$2.06-1.44%-$75.84M-1.48x0.12
United States
SSII
SS INNOVATIONS INTERNATIONAL INC
NASDAQ
Medical Devices
$1.03B$5.30-5.86%-$13.45M-58.89x0.67
United States
ARDX
ARDELYX INC
NASDAQ
Biotechnology
$1.49B$6.19-3.58%-$33.98M-26.91x2.35
United States
MGTX
MEIRAGTX HOLDINGS PLC
NASDAQ
Biotechnology
$589.68M$7.330.14%-$132.06M-3.59x66.13
United States
HRTX
HERON THERAPEUTICS INC
NASDAQ
Biotechnology
$184.60M$1.21-2.42%-$2.95M-24.20x-9.29
United States
RLAY
RELAY THERAPEUTICS INC
NASDAQ
Biotechnology
$701.21M$4.09-0.97%-$328.11M-1.86x0.11
United States
ALGS
ALIGOS THERAPEUTICS INC
NASDAQ
Biotechnology
$56.72M$9.223.02%-$58.76M-0.73x0.32
United States
RYTM
RHYTHM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$6.38B$96.100.61%-$159.64M-31.93x-20.08
United States
MLYS
MINERALYS THERAPEUTICS INC
NASDAQ
Biotechnology
$2.47B$37.29-0.35%-$190.72M-10.47x0.07
United States
INSM
INSMED INC
NASDAQ
Biotechnology
$26.37B$144.780.02%-$914.73M-24.41x17.18
United States
EUDA
EUDA HEALTH HOLDINGS LTD
NASDAQ
Health Information Services
$39.01M$1.05-4.55%-$15.14M-2.23x-1.67
Singapore
LEGN
LEGEND BIOTECH CORP
NASDAQ
Biotechnology
$6.36B$34.470.38%-$260.04M-19.37x0.63
United States
CBLL
CERIBELL INC
NASDAQ
Medical Devices
$438.13M$11.952.40%-$46.14M-12.45x0.21
United States
IART
INTEGRA LIFESCIENCES HOLDINGS CORP
NASDAQ
Medical Devices
$1.15B$14.80-0.20%-$332.63M-2.27x2.53
United States
IMNM
IMMUNOME INC
NASDAQ
Biotechnology
$782.53M$8.99-1.10%-$209.77M-2.92x0.10
United States
MOH
MOLINA HEALTHCARE INC
NYSE
Healthcare Plans
$9.56B$176.32-0.07%$1.85B8.66x2.52
United States
NRC
NATIONAL RESEARCH CORP
NASDAQ
Health Information Services
$362.52M$15.91-0.93%$41.22M15.30x3.56
United States
RNAC
CARTESIAN THERAPEUTICS INC
NASDAQ
Biotechnology
$237.48M$9.15-4.69%-$33.79M-8.32x-19.78
United States
TVRD
TVARDI THERAPEUTICS INC
NASDAQ
Biotechnology
$366.09M$39.0415.40%-$13.45M-2.41x0.33
United States
STRO
SUTRO BIOPHARMA INC
NASDAQ
Biotechnology
$72.05M$0.85-4.37%-$205.86M-0.29x-13.45
United States
ATAI
ATAI LIFE SCIENCES NV
NASDAQ
Biotechnology
$988.10M$4.61-0.86%-$115.37M-6.68x0.32
United States
GH
GUARDANT HEALTH INC
NASDAQ
Diagnostics & Research
$7.13B$57.193.23%-$368.35M-17.07x-5.36
United States
LNTH
LANTHEUS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$3.46B$50.84-2.19%$457.27M12.94x0.81
United States
NPCE
NEUROPACE INC
NASDAQ
Medical Devices
$327.18M$9.890.92%-$15.52M-11.92x4.46
United States
XNCR
XENCOR INC
NASDAQ
Biotechnology
$659.74M$9.257.31%-$123.36M-3.90x0.42
United States
LCTX
LINEAGE CELL THERAPEUTICS INC
NYSEMKT
Biotechnology
$317.42M$1.390.72%-$40.28M-7.72x0.90
United States
ALT
ALTIMMUNE INC
NASDAQ
Biotechnology
$315.08M$3.57-1.65%-$88.03M-3.03x0.18
United States
NTRA
NATERA INC
NASDAQ
Diagnostics & Research
$23.95B$175.430.24%-$131.49M-119.34x0.40
United States
MNPR
MONOPAR THERAPEUTICS
NASDAQ
Biotechnology
$411.17M$66.6416.91%-$17.31M-17.31x0.03
United States
CNC
CENTENE CORP
NYSE
Healthcare Plans
$15.73B$32.020.69%$4.71B7.77x2.15
United States
CDXS
CODEXIS INC
NASDAQ
Biotechnology
$212.13M$2.35-5.62%-$46.09M-2.90x1.49
United States
BLFS
BIOLIFE SOLUTIONS INC
NASDAQ
Medical Instruments & Supplies
$1.22B$25.59-1.52%-$2.50M-71.07x0.12
United States
TNYA
TENAYA THERAPEUTICS INC
NASDAQ
Biotechnology
$198.83M$1.22-3.17%-$87.71M-1.28x0.22
United States
PASG
PASSAGE BIO INC
NASDAQ
Biotechnology
$22.35M$7.03-3.30%-$55.01M-0.39x1.07
United States
ORGO
ORGANOGENESIS HOLDINGS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$586.06M$4.62-4.94%$1.30M-27.18x0.41
United States
ARVN
ARVINAS INC
NASDAQ
Biotechnology
$558.71M$7.61-0.39%-$66.60M-7.53x0.49
United States
NRIX
NURIX THERAPEUTICS INC
NASDAQ
Biotechnology
$655.17M$8.571.54%-$188.80M-3.28x0.32
United States
PACB
PACIFIC BIOSCIENCES OF CALIFORNIA INC
NASDAQ
Medical Devices
$369.46M$1.230.00%-$112.13M-0.69x12.43
United States
UNH
UNITEDHEALTH GROUP INC
NYSE
Healthcare Plans
$309.39B$341.610.54%$34.13B14.69x2.15
United States
PINC
PREMIER INC
NASDAQ
Health Information Services
$2.19B$26.580.76%$180.44M120.82x1.02
United States
PROK
PROKIDNEY CORP
NASDAQ
Biotechnology
$744.53M$2.53-3.44%-$65.55M-4.44x-0.03
United States
CV
CAPSOVISION INC
NASDAQ
Medical Devices
$216.56M$4.633.35%N/AN/A-0.04
United States
ANIX
ANIXA BIOSCIENCES INC
NASDAQ
Biotechnology
$110.27M$3.35-6.94%-$11.08M-9.57x0.14
United States
CCRN
CROSS COUNTRY HEALTHCARE INC
NASDAQ
Medical Care Facilities
$429.84M$13.121.86%$13.83M-50.46x0.34
United States
GLUE
MONTE ROSA THERAPEUTICS INC
NASDAQ
Biotechnology
$391.20M$6.36-1.70%$17.73M79.50x0.43
United States
SION
SIONNA THERAPEUTICS INC
NASDAQ
Biotechnology
$980.79M$22.22-4.51%N/AN/A0.05
United States
STSS
SHARPS TECHNOLOGY INC
NASDAQ
Medical Instruments & Supplies
$8.32M$8.13-4.01%$2.10M-0.01x0.18
United States
GRAL
GRAIL INC
NASDAQ
Diagnostics & Research
$1.38B$38.32-1.20%-$441.54M-3.15x0.17
United States
ADMA
ADMA BIOLOGICS INC
NASDAQ
Biotechnology
$3.71B$15.56-0.83%$163.11M17.68x0.40
United States
ALMS
ALUMIS INC
NASDAQ
Biotechnology
$429.79M$4.13-0.72%-$232.06M-1.38x0.26
United States
STTK
SHATTUCK LABS INC
NASDAQ
Biotechnology
$92.93M$1.94-9.35%-$57.29M-1.60x0.13
United States
ACIU
AC IMMUNE SA
NASDAQ
Biotechnology
$247.01M$2.46-3.15%-$59.32M-3.99x1.55
Switzerland
HYFT
MINDWALK HOLDINGS CORP
NASDAQ
Biotechnology
$71.54M$1.55-2.52%-$19.99M-2.46x0.96
Canada
ABCL
ABCELLERA BIOLOGICS INC
NASDAQ
Biotechnology
$1.36B$4.57-4.19%-$113.80M-8.16x0.31
Canada
MBIO
MUSTANG BIO INC
NASDAQ
Biotechnology
$7.05M$1.611.90%-$10.54M-0.06x3.13
United States
CLOV
CLOVER HEALTH INVESTMENTS CORP
NASDAQ
Healthcare Plans
$1.56B$3.07-1.60%-$23.63M-61.40x0.74
United States

Healthcare Industries

IndustryStocks1d %1w %1m %1y %DD ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
637+0.00%-0.05%+4.28%-48.39%-97.28x4.69x-106.22%-5.90%-9.54%+81.58%Strong Buy
56+0.05%+1.66%+0.38%-20.26%20.65x3.77x-3.54%+7.27%+15.75%+9.35%Buy
19+0.33%-0.06%+2.59%-10.66%37.55x6.02x+60.37%+10.42%+17.94%+41.73%Buy
76+0.34%+0.57%+2.73%-20.49%-27.69x2.24x+11.59%+4.57%+10.00%+34.48%Buy
11+0.03%-1.09%+1.98%-33.43%14.71x2.02x+15.85%+4.97%+11.53%+16.80%Buy
53+0.26%+0.77%-0.71%-53.88%85.39x4.12x+8.47%+5.46%+9.16%+26.70%Strong Buy
47+0.52%-0.27%+1.25%-30.69%15.87x4.80x-189.09%+6.89%+15.29%+18.16%Buy
142-0.82%-0.47%-1.49%-34.52%30.71x3.98x+13.93%+8.55%+10.12%+30.94%Strong Buy
10-0.22%-1.77%+1.56%+25.94%26.73x291.57x-9.10%+3.03%+18.79%+14.81%Buy
55-0.34%-1.32%-2.43%-67.86%29.74x3.30x+10.41%+8.32%+11.05%+26.39%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Embecta (NASDAQ:EMBC)


Embecta (NASDAQ:EMBC) is the #1 top healthcare stock out of 1106 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 10 points higher than the healthcare sector average of 25. It passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -8.73% over the past year, overperforming other healthcare stocks by 32 percentage points.

Embecta has an average 1 year price target of $18.50, an upside of 22.84% from Embecta's current stock price of $15.06.

Embecta stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Embecta, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Livanova (NASDAQ:LIVN)


Livanova (NASDAQ:LIVN) is the #2 top healthcare stock out of 1106 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Livanova (NASDAQ:LIVN) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: A.

Livanova (NASDAQ:LIVN) has a Due Diligence Score of 17, which is -8 points lower than the healthcare sector average of 25. Although this number is below the industry average, our proven quant model rates LIVN as a "A".It passed 5 out of 33 due diligence checks and has weak fundamentals. Livanova has seen its stock return 6.92% over the past year, overperforming other healthcare stocks by 48 percentage points.

Livanova has an average 1 year price target of $60.75, an upside of 11.41% from Livanova's current stock price of $54.53.

Livanova stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Livanova, 0% have issued a Strong Buy rating, 75% have issued a Buy, 25% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Infusystem Holdings (NYSEMKT:INFU)


Infusystem Holdings (NYSEMKT:INFU) is the #3 top healthcare stock out of 1106 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Infusystem Holdings (NYSEMKT:INFU) is: Value: C, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Infusystem Holdings (NYSEMKT:INFU) has a Due Diligence Score of 29, which is 4 points higher than the healthcare sector average of 25. It passed 9 out of 33 due diligence checks and has average fundamentals. Infusystem Holdings has seen its stock return 52.34% over the past year, overperforming other healthcare stocks by 93 percentage points.

Infusystem Holdings has an average 1 year price target of $12.00, an upside of 22.7% from Infusystem Holdings's current stock price of $9.78.

Infusystem Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Infusystem Holdings, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Essa Pharma (NASDAQ:EPIX)


Essa Pharma (NASDAQ:EPIX) has an annual dividend yield of 833.02%, which is 820 percentage points higher than the healthcare sector average of 12.89%.

Essa Pharma's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Select Medical Holdings (NYSE:SEM)


Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.99%, which is 2 percentage points higher than the healthcare sector average of 12.89%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

3. Cryo Cell International (NYSEMKT:CCEL)


Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of 9.07%, which is -4 percentage points lower than the healthcare sector average of 12.89%.

Cryo Cell International's dividend payout ratio of -2,166.7% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.05% in the last day, and down 0% over the last week. Co Diagnostics was the among the top losers in the healthcare sector, dropping -34.74% yesterday.

Co-Diagnostics shares are trading lower after the company announced a $3.8 million registered direct offering of 9.619 million shares at a price of $0.40 per share.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -17.39% in the past year. It has overperformed other stocks in the healthcare sector by 24 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 66.92% in the past year. It has overperformed other stocks in the healthcare sector by 108 percentage points.

3. Embecta (NASDAQ:EMBC)


Embecta (NASDAQ:EMBC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -8.73% in the past year. It has overperformed other stocks in the healthcare sector by 32 percentage points.

Are healthcare stocks a good buy now?

50.37% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 41.77% over the next year.

4.6% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.51% of healthcare stocks are rated B (Buy), 45.81% are rated C (Hold), 26.45% are rated D (Sell), and 10.63% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 9.66x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.